Nexalin Technology NXL
NASDAQ NXL
$4.21 -0.14 (-3.22%)
At close: Sep 30, 2026 · 4:00 PM EDT

Nexalin Technology (NXL) Total Debt (2021 - 2023)

Updated

Nexalin Technology (NXL) posted Total Debt of $500,000 for Q3 2023, unchanged from $500,000 a year earlier and unchanged from the prior quarter.

Analysis

Nexalin Technology (NXL) Total Debt (2021 - 2023) Analysis & Trends

Since Q4 2021, Nexalin Technology has reported Total Debt for 6 quarters.

  • In prior years, Nexalin Technology's Total Debt was $560,116 in FY2021.
  • Quarterly Total Debt has run from a low of $500,000 in Q3 2022 to a high of $560,116 in Q4 2021 over five years.
  • According to Business Quant data, Total Debt for the three prior quarters was $500,000 (Q2 2023), $500,000 (Q1 2023) and $500,000 (Q4 2022).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Thermo Fisher Scientific 249.71 Bn 228.86 Bn 4.88 Bn 42.55 Bn
2 Abbott Laboratories 171.00 Bn 142.08 Bn 7.27 Bn 32.61 Bn
3 Danaher 155.79 Bn 139.61 Bn 3.61 Bn 26.56 Bn
4 Intuitive Surgical 143.91 Bn 123.46 Bn 1.96 Bn -
5 Medtronic 110.42 Bn 76.29 Bn 6.34 Bn 28.15 Bn
6 Stryker 105.71 Bn 91.82 Bn 4.50 Bn 14.94 Bn
7 Boston Scientific 63.26 Bn 58.27 Bn 3.85 Bn 12.62 Bn
8 Edwards Lifesciences 49.80 Bn 33.91 Bn 1.35 Bn 598.70 Mn
9 Becton Dickinson 48.78 Bn 45.93 Bn 2.32 Bn 16.81 Bn
10 Nexalin Technology 3.09 Mn -8.70 Mn 8,897.00 -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 500,000.00
Jun 30, 2023 500,000.00
Mar 31, 2023 500,000.00
Dec 31, 2022 500,000.00
Sep 30, 2022 500,000.00
Dec 31, 2021 560,116.00
API Access

Nexalin Technology Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=NXL&period=max&api_key=YOUR_API_KEY